CMS Strategy Weekly (20 Feb 2023) Rate expectations see upward revision
ESOP targets stabilize earnings expectation but sentiment overhang remains
–1H23 worse than expected on slow recovery; Maintain HOLD
China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters
3Q NPAT boosted by net fair value gains; expect resilient full-year NBV upswing
Can Fiscal Consolidation Announcements Help Anchor Inflation Expectations?
Expect domestic business to rebound from 2025
China Property Sector: Property+ Weekly: Can we expect post-CNY recovery?
China Property SectorNBS Nov data in line, expect new policy in BJ／SH to boost secondary market in Dec
Expect Shengyi to enter Nvidia supply chain in 2024
公众号
小程序
社群
公众号小程序社群